Menu
We have a diverse and differentiated portfolio of value-added medicines to meet the ever-evolving needs of healthcare. Our committment to providing reliable and consistent supplies of high-quality medicines is improving the lives of our community.
We collaborate with an extensive network of global partners to expedite new product development and launches. Our commitment to commercial excellence, combined with a proven track record in regulatory compliance and project management, has enabled us to deliver medicines to patients on time, while meeting business expectations.
Discover the new Kent-Athlone Pharma Group Medicines Database where you can view and download the Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL), for all products supplied by Kent Pharma UK Ltd.

Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Adverse events should also be reported to Kent Pharma UK Ltd.
For a copy of the SmPC or further medical information, please contact: medical@kent-athlone.com.